HOFFMANN, J. C., HERKLOTZ, C., ZEIDLER, H., BAYER, B., & WESTERMANN, J. (1997). Anti-CD2 (OX34) MoAb treatment of adjuvant arthritic rats: Attenuation of established arthritis, selective depletion of CD4(+) T cells, and CD2 down-modulation. Blackwell Science Inc.
Citação norma ChicagoHOFFMANN, J C., C. HERKLOTZ, H. ZEIDLER, B. BAYER, and J. WESTERMANN. Anti-CD2 (OX34) MoAb Treatment of Adjuvant Arthritic Rats: Attenuation of Established Arthritis, Selective Depletion of CD4(+) T Cells, and CD2 Down-modulation. Blackwell Science Inc, 1997.
MLA CitationHOFFMANN, J C., et al. Anti-CD2 (OX34) MoAb Treatment of Adjuvant Arthritic Rats: Attenuation of Established Arthritis, Selective Depletion of CD4(+) T Cells, and CD2 Down-modulation. Blackwell Science Inc, 1997.